Neuroblastoma
Research in the area of neuroblastoma reported from E. Grau and colleagues
Published in Cancer Weekly, May 5th, 2009
"Cancer/testis-specific antigens MAGE-A1 and MAGE-A3 genes were proposed as minimal residual disease (MRD) markers in neuroblastoma, but its usefulness for this purpose is rather limited. We studied 47 primary neuroblastoma tumors. RNA was extracted and cDNA was prepared by reverse transcription. Detection of the MAGE-A1 expression was done by hybridization of the RT-PCR products. We used methylation-specific-PCR to perform the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-05-05)
More Articles from Cancer Weekly
- Brain Cancer
Study results from Brain Tumor Center provide new insights into brain cancer - Cancer Gene Therapy
Research conducted at University of Marburg, Medical Department has updated our knowledge about cancer gene therapy - Cancer Gene Therapy
Research reports on cancer gene therapy from I. Gentschev and colleagues provide new insights - Cancer Vaccines
Newly published study shows that re-treatment with PegasysŪ (peginterferon alfa-2a) provides hepatitis C patients with a second chance for a cure - Cancer Vaccines
Reports from Baylor College of Medicine, College of Medicine describe recent advances in cancer vaccines - Cancer Vaccines
Researchers from University of Georgia report details of new studies and findings in the area of cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
